Inflammation Research

, Volume 68, Issue 1, pp 1–6 | Cite as

Altered regulation of the T-cell system in patients with CRPS

  • Jens HeynEmail author
  • Shahnaz C. Azad
  • Benjamin Luchting
Short Communication


The aim of this study was to investigate T-cell subsets and immunomodulatory factors in patients with complex regional pain syndrome (CRPS). We found decreased numbers of pro-inflammatory Th17 cells in patients with CRPS as compared to healthy volunteers. The expression of Th17 related RORγT mRNA was also significantly decreased. Patients with CRPS showed an increased proportion of CD39+ Tregs. CD39 is a known inhibitor of Th17 cell differentiation. Systemic cytokine levels were almost unchanged in patients with CRPS. These findings suggest that the decrease in Th17 cells in CRPS is regulated by an increase in CD39+ Tregs and that this anti-inflammatory T-cell shift may be a mechanism to control inflammation in CRPS.

German clinical trial register

Registration Trial DRKS00005954.


CRPS Th17 cells CD39 Inflammation. 



The authors are grateful to G. Groeger and J. Rink for excellent technical assistance.

Compliance with ethical standards

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


  1. 1.
    Bruehl S. An update on the pathophysiology of complex regional pain syndrome. Anesthesiology. 2010;113:713–25.Google Scholar
  2. 2.
    Raja SN, Grabow TS. Complex regional pain syndrome I (reflex sympathetic dystrophy). Anesthesiology. 2002;96:1254–60.CrossRefGoogle Scholar
  3. 3.
    Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007;8:326–31.CrossRefGoogle Scholar
  4. 4.
    Hu P, Bembrick AL, Keay KA, McLachlan EM. Immune cell involvement in dorsal root ganglia and spinal cord after chronic constriction or transection of the rat sciatic nerve. Brain Behav Immun. 2007;21:599–616.CrossRefGoogle Scholar
  5. 5.
    Kaufmann I, Eisner C, Richter P, Huge V, Beyer A, Chouker A, Schelling G, Thiel M. Lymphocyte subsets and the role of TH1/TH2 balance in stressed chronic pain patients. Neuroimmunomodulation. 2007;14:272–80.CrossRefGoogle Scholar
  6. 6.
    Luchting B, Rachinger-Adam B, Zeitler J, Egenberger L, Möhnle P, Kreth S, Azad SC. Disrupted TH17/Treg balance in patients with chronic low back pain. PLoS One. 2014;9:e104883.CrossRefGoogle Scholar
  7. 7.
    Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Höpner S, Centonze D, Bernardi G, Dell’Acqua ML, Rossini PM, Battistini L, Rötzschke O, Falk K. Expression of ectonucleotidase CD39 by Foxp3 + Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225–32.CrossRefGoogle Scholar
  8. 8.
    Ye ZJ, Zhou Q, Zhang JC, Li X, Wu C, Qin SM, Xin JB, Shi HZ. CD39 + regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism. Respir Res. 2011;12:77.CrossRefGoogle Scholar
  9. 9.
    Heyn J, Luchting B, Hinske LC, Hübner M, Azad SC, Kreth S. miR-124a and miR-155 enhance differentiation of regulatory T cells in patients with neuropathic pain. J Neuroinflammation. 2016;13:248.CrossRefGoogle Scholar
  10. 10.
    Luchting B, Rachinger-Adam B, Heyn J, Hinske LC, Kreth S, Azad SC. Anti-inflammatory T-cell shift in neuropathic pain. J Neuroinflammation. 2015;12:12.CrossRefGoogle Scholar
  11. 11.
    Bharwani KD, Dirckx M, Stronks DL, Dik WA, Schreurs MWJ, Huygen FJPM. Elevated Plasma Levels of sIL-2R in Complex Regional Pain Syndrome: A Pathogenic Role for T-Lymphocytes? Mediators Inflamm. 2017;2017:2764261.CrossRefGoogle Scholar
  12. 12.
    Haas JD, Nistala K, Petermann F, Saran N, Chennupati V, Schmitz S, Jing W, Jiang W. Expression of miRNAs miR-133b and miR-206 in the Il17a/f locus is co-regulated with IL-17 production in αβ and γδ T cells. PLoS One. 2011;6:e20171.CrossRefGoogle Scholar
  13. 13.
    Tang X, Tian X, Zhang Y, Wu W, Tian J, Rui K, Tong J, Lu L, Xu H, Wang S. Correlation between the frequency of Th17 cell and the expression of microRNA-206 in patients with dermatomyositis. Clin Dev Immunol. 2013;2013:345347.Google Scholar
  14. 14.
    Huygen FJ, Ramdhani N, van Toorenenbergen A, Klein J, Zijlstra FJ. Mast cells are involved in inflammatory reactions during complex regional pain syndrome type 1. Immunol Lett. 2004;91:147–54.CrossRefGoogle Scholar
  15. 15.
    Ambros V. The functions of animal microRNAs. Nature. 2004;431:350–5.CrossRefGoogle Scholar
  16. 16.
    Orlova IA, Alexander GM, Qureshi RA, Sacan A, Graziano A, Barrett JE, Schwartzman RJ, Ajit SK. MicroRNA modulation in complex regional pain syndrome. J Transl Med. 2011;9:195.CrossRefGoogle Scholar
  17. 17.
    Yao R, Ma YL, Liang W, Li HH, Ma ZJ, Yu X, Liao YH. MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS One. 2012;7:e46082.CrossRefGoogle Scholar
  18. 18.
    Wang H, Flach H, Onizawa M, Wei L, McManus MT, Weiss A. Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210. Nat Immunol. 2014;15:393–401.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.Department of AnesthesiologyLudwig-Maximilians-Universität München (LMU)MunichGermany

Personalised recommendations